The Midazolam Hydrochloride Injectio, cataloged under National Stock Number 6505-01-523-1382, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Baxter Healthcare Corporation. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-523-1382 |
| Primary Part Number | 1001902703 |
| Item Name | Midazolam Hydrochloride Injectio |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Baxter Healthcare Corporation |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE IV |
| Primary Container Content Quantity | 1.000 MILLILITERS |
| Primary Container Type | VIAL |
| American Hospital Formulary Service Classification Number | 282408 |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 1001902703 PRIMARY | Baxter Healthcare Corporation (USA) |
| Reference | Meaning |
|---|---|
| NDC10019-0027-03 | 3/9 Design control — primary reference Baxter Healthcare Corporation Div Medication Delivery |
| 04-1221 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-523-1382 is a Midazolam Hydrochloride Injectio, manufactured by Baxter Healthcare Corporation, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-523-1382 has 1 manufacturer part number on file: 1001902703 (Baxter Healthcare Corporation).
Key specifications for 1001902703: Controlled Substance Classification: SCHEDULE IV; Primary Container Content Quantity: 1.000 MILLILITERS; Primary Container Type: VIAL; Special Features: FOR USE TO PROVIDE SEDATION BEFORE SURGERY OR DURING DIAGNOSTIC PROCEDURES; STORE PRODUCT AT ROOM TEMPERATURE (15-30 DEG. C). 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.